Form D · Biotechnology
Polybiotics LLC
Hamden, CT · CIK 0001491097
Offering snapshot reported May 6, 2010 · SEC filing
- Reported sold
- $175K Offering amount: $200K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 23, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 6, 2010 | Initial | $175,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-141617
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed May 6, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George L. Discher | Director, Executive |
| Douglas Hanlon | Director, Executive |
| William H. Hylton | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2560 Dixwell Avenue
Hamden, CT, 06514
Hamden, CT, 06514